Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)David Keßler, Nicola Wiles, T. J. Peters et al.|BMJ|2018Cited by 84
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCTDavid Keßler, Nicola Wiles, Alison Burns et al.|Health Technology Assessment|2018Cited by 32